BREAKING: Virologist Nathan Wolfe will officially conclude his visiting appointment at Stanford University’s bioengineering department effective Monday, following revelations of his connections to late sex offender Jeffrey Epstein. This decision marks a significant move amid ongoing scrutiny of Wolfe’s professional ties and a recently published investigative report.
The appointment, which lasted for just one year, will not be renewed. Reports surfaced last week detailing Wolfe’s correspondence with Epstein, wherein he controversially invited Epstein to meet “a couple of hottie interns.” Additionally, Wolfe sought Epstein’s involvement as a donor for research on sexual behavior, specifically aimed at developing a “female viagra,” based on what Wolfe referred to as the “[their] horny virus hypothesis.”
In light of the allegations, Wolfe issued a statement denying any misconduct. He expressed regret over his association with Epstein, stating, “I never witnessed or participated in any misconduct or inappropriate behavior.” This statement has done little to quell the backlash following the report.
Previously known as the Lorey I. Lokey Visiting Professor of Human Biology, Wolfe’s LinkedIn profile indicated that he was a Visiting Scholar at the Quake Lab, where he has co-authored several academic papers. However, the profile has since been updated, suggesting his association with Stanford as a “Visiting Scholar” from 2023 until February 2026.
A spokesperson from Stanford confirmed the termination of Wolfe’s appointment, emphasizing the university’s commitment to maintaining high ethical standards. The fallout from this investigation raises critical questions about professional relationships in academia and funding sources.
As this story develops, the academic community and the public alike are keenly watching Wolfe’s next steps and any further implications of his past associations. The urgency of this situation highlights the need for transparency and accountability in academic research and funding.
Stay tuned for more updates on this developing story.
